AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Jan, 24, 2023
$AVXL Thank you to the latest generation of people... See more
Jan, 23, 2023
Hold your shares, buy if you can, the reward will ... See more
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ... See more
Feb, 27, 2023
Massive Great Post !
SHC
Sotera Health Co
-0.67%
$17.85 - $17.73
Feb 8th 2023 - Mar 22nd 2023
Jan, 19, 2023
$SHC Why all of these posts?… Because it’s fun.
Jan, 11, 2023
$SHC I’ve never seen a stock look so strong post a... See more
Jan, 24, 2023
$AVXL Thank you to the latest generation of people posting on this board and keeping the interest for AVXL up.
Jan, 23, 2023
Hold your shares, buy if you can, the reward will start very soon…😊 You can mark that post 💪🏼👍😉
Jan, 18, 2023
but positive posts.
Jan, 15, 2023
After reviewing the data, his comment was that it looked promising and worth further trials
Jan, 12, 2023
when more then 50% of the posts are people telling you to sell you know you have a great stock!.
Dec, 20, 2022
Thanks for the post.
Dec, 12, 2022
$AVXL Look at my 8:09 post when I Sold the shares made $1.02 per share not a bad day
Dec, 9, 2022
$AVXL Hey thanks for all the posts ,very informative !
Dec, 4, 2022
The first excellent poster that comes to mind IMO klaushommels Thanks Klaus I really enjoy reading your posts.
Dec, 2, 2022
$AVXL Some of the response to my posts are unbelievable.
Mar, 8, 2023
In pooled post hoc analyses of ULTIMATE I and II, ublituximab was associated with significant treatment benefit across multiple efficacy measures at Week 96 versus teriflunomide in participants who had not received prior DMT.
Feb, 27, 2023
Massive Great Post !
Feb, 21, 2023
$TGTX Three interesting posts . .
Jan, 15, 2023
$TGTX @ern1in love the posts.
Jan, 5, 2023
this should lift post 1/20 and really rocket come Q1/Q2 earnings.
Jan, 1, 2023
$TGTX Absolute pleasure to see morale up and read all the positive posts again.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 29, 2022
$HSDT $TGTX great post
Dec, 29, 2022
$TGTX post aging like a fine wine🤌🏼
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,